Eugenol nanocapsule for enhanced therapeutic activity against periodontal infections

References

• Ali J. Nanopharmaceutics. Int J Pharma Investig 2011;1:61
   PubMedGoogle Scholar
• Ajazuddin, Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010;81:680–9
   PubMed Web of Science ®Google Scholar
• Nair HB, Sung B, Yadav VR, et al. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 2010;80:1833–43
   PubMed Web of Science ®Google Scholar
• Jithan AV, Madhavi K, Madhavi M, et al. Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharma Investig 2011;1:119–25
   PubMedGoogle Scholar
• Pramod K, Ansari SH, Ali J. Eugenol: a natural compound with versatile pharmacological actions. Nat Prod Commun 2010;5:1999–2006
   PubMed Web of Science ®Google Scholar
• Jadhav BK, Khandelwal KR, Ketkar AR, et al. Formulation and evaluation of mucoadhesive nanocapsules containing eugenol for the treatment of periodontal diseases. Drug Dev Ind Pharm 2004;30:195–203
   PubMed Web of Science ®Google Scholar
• Piñón-Segundo E, Ganem-Quintanar A, Alonso-Pérez V, et al. Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int J Pharm 2005;294:217–32
   PubMed Web of Science ®Google Scholar
• Reis CP, Neufeld RJ, Ribeiro AJ, et al. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2006;2:8–21
   PubMed Web of Science ®Google Scholar
• Pramod K, Ansari SH, Ali J. Fabrication and tailoring of eugenol loaded polycaprolactone nanoparticles using response surface methodology. Adv Sci Eng Med 2013;5:1166–75
   Google Scholar
• Pramod K, Ilyas UK, Singh M, et al. High performance thin layer chromatographic analysis of eugenol in developed nanoemulsion gel and nanoparticles: validation of a stability indicating method. Acta Chromatogr 2015 . [Epub ahead of print]. doi:10.1556/AChrom.27.2015.3.12
   Web of Science ®Google Scholar
• Gupta H, Sharma A, Shrivastava B. Pluronic and chitosan based in situ gel system for periodontal application. Asian J Pharm 2009;3:94–6
   Google Scholar
• Merchant HA, Shoaib HM, Tazeen J, et al. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech 2006;7:E178–83
   Google Scholar
• Aminu N, Baboota S, Pramod K, et al. Development and evaluation of triclosan loaded poly-ε-caprolactone nanoparticulate system for the treatment of periodontal infections. J Nanopart Res 2013;15:2075. doi: 10.1007/s11051-013-2075-6
   Web of Science ®Google Scholar
• Ghosh MN. Fundamentals of experimental pharmacology. 3rd ed. Kolkata: Hilton and Company Publishers; 2005
   Google Scholar
• Freireich EJ, Gehan EA, Rall DP, et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1996;50:219–44
   Google Scholar
• Yan X, Wei W. A comparative study of systemic subantimicrobial and topical treatment of minocycline in experimental periodontitis of rats. Arch Oral Biol 2006;51:794–803
   PubMed Web of Science ®Google Scholar
• Xie R, Kuijpers-Jagtman AM, Maltha JC. Inflammatory responses in two commonly used rat models for experimental tooth movement: comparison with ligature-induced periodontitis. Arch Oral Biol 2011;56:159–67
   PubMed Web of Science ®Google Scholar
• Botelho MA, Martins JG, Ruela RS, et al. Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticules. J Appl Oral Sci 2010;18:335–42
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(ε-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen. Int J Pharm 2002;249:127–38
   PubMed Web of Science ®Google Scholar
• Ferranti V, Marchais H, Chabenat C, et al. Primidone-loaded poly-ε-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles. Int J Pharm 1999;193:107–11
   PubMed Web of Science ®Google Scholar
• Wang S, Guo S, Cheng L. Disodium norcantharidate loaded poly(ε-caprolactone) microspheres I. Preparation and evaluation. Int J Pharm 2008;350:130–7
   PubMed Web of Science ®Google Scholar
• Wang S, Guo S. Formation mechanism and release behavior of poly(ε-caprolactone) microspheres containing disodium norcantharidate. Eur J Pharm Biopharm 2008;69:1176–81
   PubMed Web of Science ®Google Scholar
• Garg A, Singh S. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Colloids Surf B Biointerfaces 2011;87:280–8
   PubMed Web of Science ®Google Scholar
• Gomes C, Moreira RG, Castell-Perez E. Poly (dl-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications. J Food Sci 2011;76:N16–24
   PubMed Web of Science ®Google Scholar
• Thonemann B, Schmalz G, Hiller KA, et al. Responses of L929 mouse fibroblasts, primary and immortalized bovine dental papilla-derived cell lines to dental resin components. Dent Mater 2002;18:318–23
   PubMed Web of Science ®Google Scholar
• Schweikl H, Schmalz G. Toxicity parameters for cytotoxicity testing of dental materials in two different mammalian cell lines. Eur J Oral Sci 1996;104:292–9
   PubMed Web of Science ®Google Scholar
• Oz HS, Puleo DA. Animal models for periodontal disease. J Biomed Biotechnol 2011;2011:754857
   PubMedGoogle Scholar
• Struillou X, Boutigny H, Soueidan A, et al. Experimental animal models in periodontology: a review. Open Dent J 2010;29:37–47
   Google Scholar
• Page RC, Schroeder HE. Periodontitis in man and other animals: a comparative review. New York: Korger; 1982
   Google Scholar
• Souza DM, Ricardo LH, Prado MA, et al. The effect of alcohol consumption on periodontal bone support in experimental periodontitis in rats. J Appl Oral Sci 2006;14:443–7
   PubMedGoogle Scholar
• Duarte PM, Tezolin KR, Figueiredo LC, et al. Microbial profile of ligature-induced periodontitis in rats. Arch Oral Biol 2010;55:142–7
   PubMed Web of Science ®Google Scholar
• Muià C, Mazzon E, Maiere D, et al. Pyrrolidine dithiocarbamate reduced experimental periodontitis. Eur J Pharmacol 2006;539:205–10
   PubMed Web of Science ®Google Scholar
• Napimoga MH, Benatti BB, Lima FO, et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol 2009;9:216–22
   PubMed Web of Science ®Google Scholar